Outsourcing Expertise NegotiumBio offers end-to-end outsourcing strategy development and supplier management across diverse drug modalities, presenting a sales opportunity to biotech and pharma teams seeking to optimize external manufacturing ecosystems and reduce risk.

Modality Breadth With experience spanning cellular and gene therapies, biologics, and small molecules, there is a strong cross-modality value proposition for clients advancing multi-platform programs or transitioning portfolios into outsourced manufacturing.

Risk Mitigation A focus on holistic risk assessment, supplier due diligence, and cGMP-aligned qualification processes positions NegotiumBio to engage drug developers worried about supply chain resilience and compliance in global sourcing.

Cost & Modelling Capability to model manufacturing costs via deep operations and materials market knowledge enables conversations around total cost of ownership, supplier selection, and optimization of outsourcing economics for programs at scale.

Global Reach Presence across the US and Europe and readiness to manage supplier relationships offers potential to support multinational programs, ensure alignment with regional regulatory expectations, and streamline cross-border sourcing for large pharma partners.